{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:36:51Z","timestamp":1785317811274,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Theranica"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11916-025-01426-8","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:59:18Z","timestamp":1764248358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Mechanism of Action of Remote Electrical Neuromodulation (REN) in Treating Migraine and Potentially Other Idiopathic Pain Conditions"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-2084","authenticated-orcid":false,"given":"Marius","family":"Birlea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6276-9056","authenticated-orcid":false,"given":"Christopher L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5076-7427","authenticated-orcid":false,"given":"Eden","family":"Mama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-6447","authenticated-orcid":false,"given":"Alit","family":"Stark-Inbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-4978","authenticated-orcid":false,"given":"Alon","family":"Ironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9747-7773","authenticated-orcid":false,"given":"Daniel","family":"Atashsokhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8383-8444","authenticated-orcid":false,"given":"Thomas","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"1426_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0304-3959(79)90049-6","volume":"6","author":"D Le Bars","year":"1979","unstructured":"Le Bars D, Dickenson AH, Besson J-M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain. 1979;6:283\u2013304. https:\/\/doi.org\/10.1016\/0304-3959(79)90049-6.","journal-title":"Pain"},{"key":"1426_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/jn.1987.58.2.327","volume":"58","author":"J Sandkuhler","year":"1987","unstructured":"Sandkuhler J, Fu QG, Zimmermann M. Spinal pathways mediating tonic or stimulation-produced descending inhibition from the periaqueductal gray or nucleus Raphe Magnus are separate in the cat. J Neurophysiol. 1987;58:327\u201341. https:\/\/doi.org\/10.1152\/jn.1987.58.2.327.","journal-title":"J Neurophysiol"},{"key":"1426_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553\u2013622. https:\/\/doi.org\/10.1152\/physrev.00034.2015.","journal-title":"Physiol Rev"},{"key":"1426_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2013.05.041","volume":"548","author":"R Treister","year":"2013","unstructured":"Treister R, Pud D, Eisenberg E. The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans. Neurosci Lett. 2013;548:115\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2013.05.041.","journal-title":"Neurosci Lett"},{"key":"1426_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66:355\u2013474. https:\/\/doi.org\/10.1016\/S0301-0082(02)00009-6.","journal-title":"Prog Neurobiol"},{"key":"1426_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/j.pain.0000000000000499","volume":"157","author":"R-D Treede","year":"2016","unstructured":"Treede R-D. Gain control mechanisms in the nociceptive system. Pain. 2016;157:1199\u2013204. https:\/\/doi.org\/10.1097\/j.pain.0000000000000499.","journal-title":"Pain"},{"key":"1426_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1177\/0333102417735851","volume":"38","author":"D Levy","year":"2018","unstructured":"Levy D, Abdian L, Dekel-Steinkeller M, Defrin R. Experimental evidence for weaker endogenous inhibition of trigeminal pain than extra-trigeminal pain in healthy individuals. Cephalalgia. 2018;38:1307\u201315. https:\/\/doi.org\/10.1177\/0333102417735851.","journal-title":"Cephalalgia"},{"key":"1426_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-0348-8753-3_1","volume-title":"Pain neurogenic inflamm","author":"AJ Fox","year":"1999","unstructured":"Fox AJ. A comparative discussion of A\u03b4 and C fibres in different tissues. In: Brain SD, Moore PK, editors. Pain neurogenic inflamm. Basel: Birkh\u00e4user Basel; 1999. pp. 1\u201322. https:\/\/doi.org\/10.1007\/978-3-0348-8753-3_1."},{"key":"1426_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1113\/jphysiol.1987.sp016658","volume":"389","author":"D Bouhassira","year":"1987","unstructured":"Bouhassira D, Le Bars D, Villanueva L. Heterotopic activation of A delta and C fibres triggers inhibition of trigeminal and spinal convergent neurones in the rat. J Physiol. 1987;389:301\u201317. https:\/\/doi.org\/10.1113\/jphysiol.1987.sp016658.","journal-title":"J Physiol"},{"key":"1426_CR10","unstructured":"Le Bars D, Villanueva L, Bouhassira D, Willer JC. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol Fiziol Eksp Ter 1992:55\u201365."},{"key":"1426_CR11","first-page":"113","volume":"28","author":"L Villanueva","year":"1995","unstructured":"Villanueva L, Le Bars D. The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls. Biol Res. 1995;28:113\u201325.","journal-title":"Biol Res"},{"key":"1426_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1468-2982.2006.01130.x","volume":"26","author":"G Sandrini","year":"2006","unstructured":"Sandrini G, Rossi P, Milanov I, Serrao M, Cecchini A, Nappi G. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia. 2006;26:782\u20139. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01130.x.","journal-title":"Cephalalgia"},{"key":"1426_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0006-8993(82)90718-1","volume":"236","author":"D Chitour","year":"1982","unstructured":"Chitour D, Dickenson AH, Le Bars D. Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC). Brain Res. 1982;236:329\u201337. https:\/\/doi.org\/10.1016\/0006-8993(82)90718-1.","journal-title":"Brain Res"},{"key":"1426_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0006-8993(82)90384-5","volume":"231","author":"E Kraus","year":"1982","unstructured":"Kraus E, Besson J-M, Bars DL. Behavioral model for diffuse noxious inhibitory controls (DNIC): potentiation by 5-hydroxytryptophan. Brain Res. 1982;231:461\u20135. https:\/\/doi.org\/10.1016\/0006-8993(82)90384-5.","journal-title":"Brain Res"},{"key":"1426_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/SPC.0000000000000055","volume":"8","author":"MH Ossipov","year":"2014","unstructured":"Ossipov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain. Current Opinion in Supportive & Palliative Care. 2014;8:143\u201351. https:\/\/doi.org\/10.1097\/SPC.0000000000000055.","journal-title":"Current Opinion in Supportive & Palliative Care"},{"key":"1426_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/smrv.2002.0224","volume":"7","author":"H Foo","year":"2003","unstructured":"Foo H, Mason P. Brainstem modulation of pain during sleep and waking. Sleep Med Rev. 2003;7:145\u201354. https:\/\/doi.org\/10.1053\/smrv.2002.0224.","journal-title":"Sleep Med Rev"},{"key":"1426_CR17","doi-asserted-by":"publisher","first-page":"e35293","DOI":"10.1371\/journal.pone.0035293","volume":"7","author":"M Hossaini","year":"2012","unstructured":"Hossaini M, Goos JAC, Kohli SK, Holstege JC. Distribution of glycine\/GABA neurons in the ventromedial medulla with descending spinal projections and evidence for an ascending glycine\/GABA projection. PLoS ONE. 2012;7:e35293. https:\/\/doi.org\/10.1371\/journal.pone.0035293.","journal-title":"PLoS ONE"},{"key":"1426_CR18","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1523\/JNEUROSCI.4856-05.2006","volume":"26","author":"G Kato","year":"2006","unstructured":"Kato G, Yasaka T, Katafuchi T, Furue H, Mizuno M, Iwamoto Y, et al. Direct GABAergic and glycinergic inhibition of the substantia gelatinosa from the rostral ventromedial medulla revealed by in vivo patch-clamp analysis in rats. J Neurosci. 2006;26:1787\u201394. https:\/\/doi.org\/10.1523\/JNEUROSCI.4856-05.2006.","journal-title":"J Neurosci"},{"key":"1426_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.pain.2008.09.009","volume":"140","author":"MM Morgan","year":"2008","unstructured":"Morgan MM, Whittier KL, Hegarty DM, Aicher SA. Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla. Pain. 2008;140:376\u201386. https:\/\/doi.org\/10.1016\/j.pain.2008.09.009.","journal-title":"Pain"},{"key":"1426_CR20","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.1523\/JNEUROSCI.5389-09.2010","volume":"30","author":"F Wei","year":"2010","unstructured":"Wei F, Dubner R, Zou S, Ren K, Bai G, Wei D, et al. Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci. 2010;30:8624\u201336. https:\/\/doi.org\/10.1523\/JNEUROSCI.5389-09.2010.","journal-title":"J Neurosci"},{"key":"1426_CR21","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1152\/jn.00676.2006","volume":"96","author":"CW Winkler","year":"2006","unstructured":"Winkler CW, Hermes SM, Chavkin CI, Drake CT, Morrison SF, Aicher SA. Kappa opioid receptor (KOR) and GAD67 immunoreactivity are found in off and neutral cells in the rostral ventromedial medulla. J Neurophysiol. 2006;96:3465\u201373. https:\/\/doi.org\/10.1152\/jn.00676.2006.","journal-title":"J Neurophysiol"},{"key":"1426_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.brainres.2009.05.001","volume":"1280","author":"A Dogrul","year":"2009","unstructured":"Dogrul A, Ossipov MH, Porreca F. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res. 2009;1280:52\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2009.05.001.","journal-title":"Brain Res"},{"key":"1426_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pain.2008.11.009","volume":"141","author":"A Brenchat","year":"2009","unstructured":"Brenchat A, Romero L, Garc\u00eda M, Pujol M, Burgue\u00f1o J, Torrens A, et al. 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain. 2009;141:239\u201347. https:\/\/doi.org\/10.1016\/j.pain.2008.11.009.","journal-title":"Pain"},{"key":"1426_CR24","doi-asserted-by":"publisher","first-page":"e18252","DOI":"10.1371\/journal.pone.0018252","volume":"6","author":"F Lindstedt","year":"2011","unstructured":"Lindstedt F, Berrebi J, Greayer E, Lonsdorf TB, Schalling M, Ingvar M, et al. Conditioned pain modulation is associated with common polymorphisms in the serotonin transporter gene. PLoS One. 2011;6:e18252. https:\/\/doi.org\/10.1371\/journal.pone.0018252.","journal-title":"PLoS One"},{"key":"1426_CR25","doi-asserted-by":"publisher","unstructured":"Sanada T, Kohase H, Makino K, Umino M. Effects of alpha-adrenergic agonists on pain modulation in diffuse noxious inhibitory control 2009. https:\/\/doi.org\/10.11480\/jmds.560102","DOI":"10.11480\/jmds.560102"},{"key":"1426_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pneurobio.2006.08.001","volume":"80","author":"A Pertovaara","year":"2006","unstructured":"Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol. 2006;80:53\u201383. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.08.001.","journal-title":"Prog Neurobiol"},{"key":"1426_CR27","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1152\/jn.1998.80.5.2244","volume":"80","author":"D Budai","year":"1998","unstructured":"Budai D, Harasawa I, Fields HL. Midbrain Periaqueductal Gray (PAG) inhibits nociceptive inputs to Sacral Dorsal Horn nociceptive neurons through \u03b1<Subscript>2<\/Subscript>-adrenergic receptors. J Neurophysiol. 1998;80:2244\u201354. https:\/\/doi.org\/10.1152\/jn.1998.80.5.2244.","journal-title":"J Neurophysiol"},{"key":"1426_CR28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0022-3565(25)23146-9","volume":"255","author":"MH Ossipov","year":"1990","unstructured":"Ossipov MH, Harris S, Lloyd P, Messineo E. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. J Pharmacol Exp Ther. 1990;255:1107\u201316. https:\/\/doi.org\/10.1016\/S0022-3565(25)23146-9.","journal-title":"J Pharmacol Exp Ther"},{"key":"1426_CR29","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/00000542-199012000-00022","volume":"73","author":"MH Ossipov","year":"1990","unstructured":"Ossipov MH, Harris S, Lloyd P, Messineo E, Lin B-S, Bagley J. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology. 1990;73:1227\u201335. https:\/\/doi.org\/10.1097\/00000542-199012000-00022.","journal-title":"Anesthesiology"},{"key":"1426_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1124\/jpet.300.1.282","volume":"300","author":"CA Fairbanks","year":"2002","unstructured":"Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL. \u03b12C-adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther. 2002;300:282\u201390. https:\/\/doi.org\/10.1124\/jpet.300.1.282.","journal-title":"J Pharmacol Exp Ther"},{"key":"1426_CR31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0306-4522(98)00673-3","volume":"91","author":"JE Holden","year":"1999","unstructured":"Holden JE, Schwartz EJ, Proudfit HK. Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by \u03b11- and \u03b12-adrenoceptors. Neuroscience. 1999;91:979\u201390. https:\/\/doi.org\/10.1016\/S0306-4522(98)00673-3.","journal-title":"Neuroscience"},{"key":"1426_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/j.1532-2149.2012.00129.x","volume":"16","author":"Y Baba","year":"2012","unstructured":"Baba Y, Kohase H, Oono Y, Fujii-Abe K, Arendt\u2010Nielsen L. Effects of Dexmedetomidine on conditioned pain modulation in humans. Eur J Pain. 2012;16:1137\u201347. https:\/\/doi.org\/10.1002\/j.1532-2149.2012.00129.x.","journal-title":"Eur J Pain"},{"key":"1426_CR33","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.pain.2012.02.021","volume":"153","author":"D Yarnitsky","year":"2012","unstructured":"Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation predicts Duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153:1193\u20138. https:\/\/doi.org\/10.1016\/j.pain.2012.02.021.","journal-title":"Pain"},{"key":"1426_CR34","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jpain.2012.07.005","volume":"13","author":"GN Lewis","year":"2012","unstructured":"Lewis GN, Rice DA, McNair PJ. Conditioned pain modulation in populations with chronic pain: a systematic review and meta-analysis. J Pain. 2012;13:936\u201344. https:\/\/doi.org\/10.1016\/j.jpain.2012.07.005.","journal-title":"J Pain"},{"key":"1426_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/head.14601","volume":"63","author":"H Nahman-Averbuch","year":"2023","unstructured":"Nahman-Averbuch H, Callahan D, Darken R, Haroutounian S. Harnessing the conditioned pain modulation response in migraine diagnosis, outcome prediction, and treatment\u2014a narrative review. Headache J Head Face Pain. 2023;63:1167\u201377. https:\/\/doi.org\/10.1111\/head.14601.","journal-title":"Headache J Head Face Pain"},{"key":"1426_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejpain.2011.06.008","volume":"16","author":"H-Y Ge","year":"2012","unstructured":"Ge H-Y, Nie H, Graven\u2010Nielsen T, Danneskiold\u2010Sams\u00f8e B, Arendt\u2010Nielsen L. Descending pain modulation and its interaction with peripheral sensitization following sustained isometric muscle contraction in fibromyalgia. Eur J Pain. 2012;16:196\u2013203. https:\/\/doi.org\/10.1016\/j.ejpain.2011.06.008.","journal-title":"Eur J Pain"},{"key":"1426_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pain.2009.03.018","volume":"144","author":"KB Jensen","year":"2009","unstructured":"Jensen KB, Kosek E, Petzke F, Carville S, Fransson P, Marcus H, et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain. 2009;144:95\u2013100. https:\/\/doi.org\/10.1016\/j.pain.2009.03.018.","journal-title":"Pain"},{"key":"1426_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","volume":"114","author":"N Julien","year":"2005","unstructured":"Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114:295\u2013302. https:\/\/doi.org\/10.1016\/j.pain.2004.12.032.","journal-title":"Pain"},{"key":"1426_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0304-3959(96)03295-2","volume":"70","author":"E Kosek","year":"1997","unstructured":"Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain. 1997;70:41\u201351. https:\/\/doi.org\/10.1016\/S0304-3959(96)03295-2.","journal-title":"Pain"},{"key":"1426_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00002508-199709000-00003","volume":"13","author":"S Lautenbacher","year":"1997","unstructured":"Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain. 1997;13:189\u201396. https:\/\/doi.org\/10.1097\/00002508-199709000-00003.","journal-title":"Clin J Pain"},{"key":"1426_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4088\/JCP.08m04969blu","volume":"72","author":"E Normand","year":"2011","unstructured":"Normand E, Potvin S, Gaumond I, Cloutier G, Corbin J-F, Marchand S. Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. J Clin Psychiatry. 2011;72:219\u201324. https:\/\/doi.org\/10.4088\/JCP.08m04969blu.","journal-title":"J Clin Psychiatry"},{"key":"1426_CR42","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ejpain.2009.12.004","volume":"14","author":"S Potvin","year":"2010","unstructured":"Potvin S, Larouche A, Normand E, De Souza JB, Gaumond I, Marchand S, et al. No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Eur J Pain. 2010;14:742\u20136. https:\/\/doi.org\/10.1016\/j.ejpain.2009.12.004.","journal-title":"Eur J Pain"},{"key":"1426_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/MCG.0000000000001181","volume":"53","author":"A Marcuzzi","year":"2019","unstructured":"Marcuzzi A, Chakiath RJ, Siddall PJ, Kellow JE, Hush JM, Jones MP, et al. Conditioned pain modulation (CPM) is reduced in irritable bowel syndrome: a systematic review and meta-analysis of CPM and the role of psychological factors. J Clin Gastroenterol. 2019;53:399\u2013408. https:\/\/doi.org\/10.1097\/MCG.0000000000001181.","journal-title":"J Clin Gastroenterol"},{"key":"1426_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejpain.2010.10.001","volume":"15","author":"R Nir","year":"2011","unstructured":"Nir R, Granovsky Y, Yarnitsky D, Sprecher E, Granot M. A psychophysical study of endogenous analgesia: the role of the conditioning pain in the induction and magnitude of conditioned pain modulation. Eur J Pain. 2011;15:491\u20137. https:\/\/doi.org\/10.1016\/j.ejpain.2010.10.001.","journal-title":"Eur J Pain"},{"key":"1426_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fneur.2020.00226","volume":"11","author":"MJ Marmura","year":"2020","unstructured":"Marmura MJ, Lin T, Harris D, Ironi A, Rosen NL. Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study. Front Neurol. 2020;11:226. https:\/\/doi.org\/10.3389\/fneur.2020.00226.","journal-title":"Front Neurol"},{"key":"1426_CR46","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","volume":"88","author":"D Yarnitsky","year":"2017","unstructured":"Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88:1250\u20135. https:\/\/doi.org\/10.1212\/WNL.0000000000003760.","journal-title":"Neurology"},{"key":"1426_CR47","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/head.13551","volume":"59","author":"D Yarnitsky","year":"2019","unstructured":"Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, et al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo\u2010controlled, multicenter trial. Headache. 2019;59:1240\u201352. https:\/\/doi.org\/10.1111\/head.13551.","journal-title":"Headache"},{"key":"1426_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2147\/JPR.S115193","volume":"9","author":"C Schoen","year":"2016","unstructured":"Schoen C, Ablin J, Ichesco E, Bhavsar R, Kochlefl L, Harris R, et al. A novel paradigm to evaluate conditioned pain modulation in fibromyalgia. J Pain Res. 2016;9:711\u20139. https:\/\/doi.org\/10.2147\/JPR.S115193.","journal-title":"J Pain Res"},{"key":"1426_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/head.14469","volume":"63","author":"SJ Tepper","year":"2023","unstructured":"Tepper SJ, Rabany L, Cowan RP, Smith TR, Grosberg BM, Torphy BD, et al. Remote electrical neuromodulation for migraine prevention: a double-blind, randomized, placebo\u2010controlled clinical trial. Headache. 2023;63:377\u201389. https:\/\/doi.org\/10.1111\/head.14469.","journal-title":"Headache"},{"key":"1426_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2217\/pmt-2023-0039","volume":"13","author":"AM Blumenfeld","year":"2023","unstructured":"Blumenfeld AM, Rabany L, Ironi A, Stark-Inbar A, Harris D, Halker Singh RB, et al. Temporal analysis of remote electric neuromodulation for the prevention of migraine. Pain Manag. 2023;13:425\u201332. https:\/\/doi.org\/10.2217\/pmt-2023-0039.","journal-title":"Pain Manag"},{"key":"1426_CR51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/head.14957","volume":"65","author":"N Cheng","year":"2025","unstructured":"Cheng N, Anderson CC, Zhang N, VanderPluym JH, Starling AJ. Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: a randomized sham-controlled study (OR-01). Am Headache Soc 67th Annu Sci Meet June 19\u201322. 2025;65:204\u20135. https:\/\/doi.org\/10.1111\/head.14957.","journal-title":"Am Headache Soc 67th Annu Sci Meet June 19\u201322"},{"key":"1426_CR52","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.150.3699.971","volume":"150","author":"R Melzack","year":"1965","unstructured":"Melzack R, Wall PD. Pain mechanisms: a new theory: A gate control system modulates sensory input from the skin before it evokes pain perception and response. Science. 1965;150:971\u20139. https:\/\/doi.org\/10.1126\/science.150.3699.971.","journal-title":"Science"},{"key":"1426_CR53","unstructured":"BrainStuff. How do Adelta and C fibers differ in sending pain information to the brain? 2019. https:\/\/brainstuff.org\/blog\/adelta-c-fibers-difference-pain-information"},{"key":"1426_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000966","volume":"6","author":"B Grosberg","year":"2021","unstructured":"Grosberg B, Rabany L, Lin T, Harris D, Vizel M, Ironi A, et al. Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study. Pain Rep. 2021;6:e966. https:\/\/doi.org\/10.1097\/PR9.0000000000000966.","journal-title":"Pain Rep"},{"key":"1426_CR55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s40122-020-00185-1","volume":"9","author":"H Nierenburg","year":"2020","unstructured":"Nierenburg H, Vieira JR, Lev N, Lin T, Harris D, Vizel M, et al. Remote electrical neuromodulation for the acute treatment of migraine in patients with chronic migraine: an open-label pilot study. Pain Ther. 2020;9:531\u201343. https:\/\/doi.org\/10.1007\/s40122-020-00185-1.","journal-title":"Pain Ther"},{"key":"1426_CR56","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/head.14042","volume":"61","author":"AD Hershey","year":"2021","unstructured":"Hershey AD, Lin T, Gruper Y, Harris D, Ironi A, Berk T, et al. Remote electrical neuromodulation for acute treatment of migraine in adolescents. Headache. 2021;61:310\u20137. https:\/\/doi.org\/10.1111\/head.14042.","journal-title":"Headache"},{"key":"1426_CR57","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12325-023-02697-6","volume":"41","author":"A Synowiec","year":"2024","unstructured":"Synowiec A, Stark-Inbar A, Weinstein M, Ironi A, Mauskop A. One-year consistent safety, utilization, and efficacy assessment of remote electrical neuromodulation (REN) for migraine treatment. Adv Ther. 2024;41:170\u201381. https:\/\/doi.org\/10.1007\/s12325-023-02697-6.","journal-title":"Adv Ther"},{"key":"1426_CR58","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1093\/pm\/pnaa299","volume":"21","author":"SJ Tepper","year":"2020","unstructured":"Tepper SJ, Lin T, Montal T, Ironi A, Dougherty C. Real-world experience with remote electrical neuromodulation in the acute treatment of migraine. Pain Med. 2020;21:3522\u20139. https:\/\/doi.org\/10.1093\/pm\/pnaa299.","journal-title":"Pain Med"},{"key":"1426_CR59","doi-asserted-by":"publisher","first-page":"753736","DOI":"10.3389\/fpain.2021.753736","volume":"2","author":"J Ailani","year":"2022","unstructured":"Ailani J, Rabany L, Tamir S, Ironi A, Starling A. Real-world analysis of remote electrical neuromodulation (REN) for the acute treatment of migraine. Front Pain Res. 2022;2:753736. https:\/\/doi.org\/10.3389\/fpain.2021.753736.","journal-title":"Front Pain Res"},{"key":"1426_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pediatrneurol.2023.02.008","volume":"142","author":"A Esparham","year":"2023","unstructured":"Esparham A, Stark-Inbar A, Jekel L, Tamir S, Rabany L, Ironi A, et al. Acute treatment of migraine in adolescents: real-world analysis of remote electrical neuromodulation (REN). Pediatr Neurol. 2023;142:51\u20135. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.02.008.","journal-title":"Pediatr Neurol"},{"key":"1426_CR61","doi-asserted-by":"publisher","first-page":"1247313","DOI":"10.3389\/fpain.2023.1247313","volume":"4","author":"TS Monteith","year":"2023","unstructured":"Monteith TS, Stark-Inbar A, Shmuely S, Harris D, Garas S, Ironi A, et al. Remote electrical neuromodulation (REN) wearable device for adolescents with migraine: a real-world study of high-frequency abortive treatment suggests preventive effects. Front Pain Res. 2023;4:1247313. https:\/\/doi.org\/10.3389\/fpain.2023.1247313.","journal-title":"Front Pain Res"},{"key":"1426_CR62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cns3.20073","volume":"2","author":"K Werner","year":"2024","unstructured":"Werner K, Gerson T, Stark-Inbar A, Shmuely S, Ironi A, Szperka CL, et al. Acute treatment of migraine in children aged 6\u2009\u2212\u200911: real\u2010world analysis of remote electrical neuromodulation (REN). Ann Child Neurol Soc. 2024;2:135\u201345. https:\/\/doi.org\/10.1002\/cns3.20073.","journal-title":"Ann Child Neurol Soc"},{"key":"1426_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/head.12601","volume":"55","author":"C Cameron","year":"2015","unstructured":"Cameron C, Kelly S, Hsieh S, Murphy M, Chen L, Kotb A, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache. 2015;55:221\u201335. https:\/\/doi.org\/10.1111\/head.12601.","journal-title":"Headache"},{"key":"1426_CR64","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","volume":"381","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, et al. Rimegepant, an oral calcitonin gene\u2013related peptide receptor antagonist, for migraine. N Engl J Med. 2019;381:142\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1811090.","journal-title":"N Engl J Med"},{"key":"1426_CR65","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","volume":"394","author":"R Croop","year":"2019","unstructured":"Croop R, Goadsby PJ, Stock DA, Conway CM, Forshaw M, Stock EG, et al. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 2019;394:737\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(19)31606-X.","journal-title":"Lancet"},{"key":"1426_CR66","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1001\/jama.2019.16711","volume":"322","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Dodick DW, Ailani J, Lu K, Finnegan M, Szegedi A, et al. Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial. JAMA. 2019;322:1887. https:\/\/doi.org\/10.1001\/jama.2019.16711.","journal-title":"JAMA"},{"key":"1426_CR67","doi-asserted-by":"publisher","unstructured":"Detke HC, Goadsby PJ, Wang S, Friedman DI, Selzler KJ, Aurora SK. Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology. 2018;91. https:\/\/doi.org\/10.1212\/WNL.0000000000006640.","DOI":"10.1212\/WNL.0000000000006640"},{"key":"1426_CR68","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2018.1212","volume":"75","author":"VL Stauffer","year":"2018","unstructured":"Stauffer VL, Dodick DW, Zhang Q, Carter JN, Ailani J, Conley RR. Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial. JAMA Neurol. 2018;75:1080. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1212.","journal-title":"JAMA Neurol"},{"key":"1426_CR69","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMoa2035908","volume":"385","author":"J Ailani","year":"2021","unstructured":"Ailani J, Lipton RB, Goadsby PJ, Guo H, Miceli R, Severt L, et al. Atogepant for the preventive treatment of migraine. N Engl J Med. 2021;385:695\u2013706. https:\/\/doi.org\/10.1056\/NEJMoa2035908.","journal-title":"N Engl J Med"},{"key":"1426_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","volume":"397","author":"R Croop","year":"2021","unstructured":"Croop R, Lipton RB, Kudrow D, Stock DA, Kamen L, Conway CM, et al. Oral rimegepant for preventive treatment of migraine: a phase 2\/3, randomised, double-blind, placebo-controlled trial. Lancet. 2021;397:51\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(20)32544-7.","journal-title":"Lancet"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-025-01426-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:03:03Z","timestamp":1771275783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-025-01426-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1426"],"URL":"https:\/\/doi.org\/10.1007\/s11916-025-01426-8","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Marius Birlea participated in an Advisory Board for Abbvie. Thomas Berk is an employee of Neura Health and Amneal Pharmaceuticals. Alit Stark-Inbar and Eden Mama are Theranica employes. Alon Ironi is Theranica Employee and stockholder. Christopher Robinson is a Section Editor of this journal in \u201cAlternative Treatments for Pain Medicine\u201d collection and has no relevant financial or non-financial interests to disclose. Daniel Atashsokhan has no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}